The H4 histamine receptor agonist, clobenpropit, suppresses human cholangiocarcinoma progression by disruption of epithelial mesenchymal transition and tumor metastasis
Fanyin Meng, Yuyan Han, Dustin Staloch, Taylor Francis, Allison Stokes, Heather Francis – 25 July 2011 – Cholangiocarcinoma (CCA) is a biliary cancer arising from damaged bile ducts. Epithelial‐mesenchymal transition (EMT) occurs as epithelial cells begin to resemble mesenchymal cells leading to increased invasion potential as the extracellular matrix (ECM) degrades. Histamine exerts its effects by way of four receptors (H1‐H4 HRs). Clobenpropit, a potent H4HR agonist, inhibits mammary adenocarcinoma growth.